These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12433349)

  • 21. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-adherence to highly active antiretroviral therapy in children attending HIV treatment clinic at harare Children's Hospital, Zimbabwe.
    Chimhuya S; Nathoo KJ; Rusakaniko S
    Cent Afr J Med; 2013; 59(9-12):63-70. PubMed ID: 29144622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral adherence and virological outcomes in HIV-positive patients in Ugu district, KwaZulu-Natal province.
    Kapiamba G; Masango T; Mphuthi D
    Afr J AIDS Res; 2016 Sep; 15(3):195-201. PubMed ID: 27681144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
    Nellen JF; Nieuwkerk PT; Burger DM; Wibaut M; Gras LA; Prins JM
    AIDS Care; 2009 Jul; 21(7):842-50. PubMed ID: 20024740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of the WebAd-Q Questionnaire to monitor adherence to HIV therapy.
    Vale FC; Santa-Helena ET; Santos MA; Carvalho WMDES; Menezes PR; Basso CR; Silva MH; Alves AM; Nemes MIB
    Rev Saude Publica; 2018; 52():62. PubMed ID: 29846437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
    Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
    Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
    Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
    AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
    Walsh JC; Mandalia S; Gazzard BG
    AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to antiretroviral therapy: are we doing enough?
    Read T; Mijch A; Fairley CK
    Intern Med J; 2003; 33(5-6):254-6. PubMed ID: 12752896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
    Sullivan PS; Campsmith ML; Nakamura GV; Begley EB; Schulden J; Nakashima AK
    PLoS One; 2007 Jun; 2(6):e552. PubMed ID: 17579723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of predictors of adherence to combination antiretroviral medication.
    Golin CE; Liu H; Hays RD; Miller LG; Beck CK; Ickovics J; Kaplan AH; Wenger NS
    J Gen Intern Med; 2002 Oct; 17(10):756-65. PubMed ID: 12390551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types.
    Gordon LL; Gharibian D; Chong K; Chun H
    AIDS Patient Care STDS; 2015 Jul; 29(7):384-8. PubMed ID: 26114665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.
    Turner BJ; Newschaffer CJ; Zhang D; Cosler L; Hauck WW
    Med Care; 2000 Sep; 38(9):911-25. PubMed ID: 10982113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)].
    Knobel H; Escobar I; Polo R; Ortega L; Martín-Conde MT; Casado JL; Codina C; Fernández J; Galindo MJ; Ibarra O; Llinas M; Miralles C; Riera M; Fumaz CR; Segador A; Segura F; Chamorro L
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):221-31. PubMed ID: 15826548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to use of electronic adherence monitoring in an HIV clinic.
    Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
    Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysis.
    Cooke CE; Lee HY; Xing S
    J Manag Care Pharm; 2014 Jan; 20(1):86-92. PubMed ID: 24372462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.
    San Lio MM; Carbini R; Germano P; Guidotti G; Mancinelli S; Magid NA; Narciso P; Palombi L; Renzi E; Zimba I; Marazzi MC
    Clin Infect Dis; 2008 May; 46(10):1609-16. PubMed ID: 18419498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.